Related party transaction

SuperSeed Capital Limited
18 June 2024
 

SUPERSEED CAPITAL LIMITED

(the "Company")

 

RELATED PARTY TRANSACTION

 

 

SuperSeed Capital Limited is a company established as a venture capital fund of funds for early-stage AI/SaaS companies. The Company invests in technology-led innovation, primarily through funds managed by SuperSeed Ventures LLP (the "Investment Manager"). The Company's principal investment to date is in SuperSeed II LP (the "Fund").

 

Following similar transactions in February 2023 and more recently in March 2024, the Company has agreed to sell a further £370,000 of its commitment in the Fund to the Investment Manager. This represents 8.8% of the Company's total commitment in the Fund of £4.20m. Of the £370,000 committed to be sold, £189,932 has been drawn in cash, which has a net investment cost of £165,478.79 (after taking into account the pro-rata share of distributions received from the Fund to date). The sale is being completed at net asset value of the Fund, which results in cash proceeds to the Company of £201,415 and represents a profit of £35,936, or 17.9% above the original purchase price. The Company's commitment to the Fund is now reduced from £4.20m to £3.83m and future returns from the Fund will be reduced pro rata.

 

The Investment Manager is a related party of the Company pursuant to the rules of the Aquis Stock Exchange. The independent directors of the Company, having exercised reasonable care, skill and diligence believe that the sale of Fund commitment is fair and reasonable as far as the shareholders of the Company are concerned.

 

 

For more information, please contact:

 

SuperSeed Capital Limited

+44(0) 203 405 3060

Mads Jensen, Investment Manager


 


VSA Capital - AQSE Corporate Adviser and Broker

+44(0) 203 005 5000

Corporate Finance: Simon Barton / Alex Cabral


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings